Cargando…

Use of botulinum toxin for movement disorders

The term movement disorders encompasses all disorders hypokinetic and hyperkinetic, which were previously known as extrapyramidal syndromes. With the definition of movement disorders and their diagnostic criteria and classifications, new studies for therapeutics could be performed. New drugs were la...

Descripción completa

Detalles Bibliográficos
Autores principales:	Camargo, Carlos Henrique Ferreira, Teive, Hélio Afonso Ghizoni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioExcel Publishing Ltd 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586173/ https://www.ncbi.nlm.nih.gov/pubmed/31258617 http://dx.doi.org/10.7573/dic.212586

Ejemplares similares

Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment
por: Camargo, Carlos Henrique Ferreira, et al.
Publicado: (2015)

Botulinum Toxin in Movement Disorders: An Update
por: Anandan, Charenya, et al.
Publicado: (2021)

“I’m gonna lose my strength, I’m gonna seize and die, And all that Jazz”! Neurological diseases in jazz legends
por: Germiniani, Francisco Manoel Branco, et al.
Publicado: (2021)

Movement Disorders in Brazil: the seminal contributions of Luiz Augusto Franco de Andrade and Egberto Reis Barbosa
por: Teive, Hélio Afonso Ghizoni, et al.
Publicado: (2021)

Thomas Willis’ legacy on the 400(th) anniversary of his birth
por: Teive, Hélio Afonso Ghizoni, et al.
Publicado: (2022)

Classification and Characteristics of Pain Associated with Parkinson's Disease
por: Young Blood, Marcelo Rezende, et al.
Publicado: (2016)

History of Botulinum Toxin Treatment in Movement Disorders
por: Jabbari, Bahman
Publicado: (2016)

The perception of apathy by caregivers of patients with dementia in Parkinson's disease
por: Camargo, Carlos Henrique Ferreira, et al.
Publicado: (2016)

Evaluation of Brain SPECT with (99m)Tc-TRODAT-1 in the Differential Diagnosis of Parkinsonism
por: Fabiani, Giorgio, et al.
Publicado: (2022)

Cognitive dysfunction in spinocerebellar ataxias
por: Teive, Helio Afonso Ghizoni, et al.
Publicado: (2009)

Dystonia in Patients with Spinocerebellar Ataxia 3 - Machado-Joseph disease: An Underestimated Diagnosis?
por: Catai, Ligia Maria Perrucci, et al.
Publicado: (2018)

Management of Functional Seizures and Functional Movement Disorder: A Cross-Sectional Comparative Study
por: Dal Pasquale, Bruno Gabriel, et al.
Publicado: (2022)

Guidelines for the use of botulinum toxin in movement disorders and spasticity
por: Jabeen, Afshan, et al.
Publicado: (2011)

Experiences on The Administration of Botulinum Toxin in Movement Disorders
por: Tuğan Yıldız, Buket, et al.
Publicado: (2021)

Cognitive impairment in Spinocerebellar ataxia type 10
por: Moro, Adriana, et al.
Publicado: (2016)

Professor Paulo Norberto Discher De Sá (1939-2022)
por: Correa, Ylmar, et al.
Publicado: (2022)

“But man is not made for defeat”: insights into Ernest Hemingway’s dementia
por: Coutinho, Léo, et al.
Publicado: (2022)

Cerebellum and Cognition Henrietta Leiner's contribution. Historical note
por: Teive, Hélio Afonso Ghizoni, et al.
Publicado: (2016)

Muscle Cramps Profile among Spinocerebellar Ataxias
por: Franklin, Gustavo Leite, et al.
Publicado: (2022)

The expulsion of Augusta Dejerine-Klumpke from the Salpêtrière Hospital: Pierre Marie's revenge
por: de Vieira, Igor Vieira, et al.
Publicado: (2022)

Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System
por: Yoshida, Kazuya
Publicado: (2022)

COVID-19: we want all the brains back!
por: Disserol, Caio César Diniz, et al.
Publicado: (2023)

Professor Paula Coutinho (1941-2022)
por: Teive, Hélio Afonso Ghizoni, et al.
Publicado: (2022)

Time to onset and duration of botulinum toxin efficacy in movement disorders
por: Ledda, Claudia, et al.
Publicado: (2022)

Reply
por: FRANKLIN, Gustavo Leite, et al.
Publicado: (2021)

The evaluation of swallowing in patients with spinocerebellar ataxia and oropharyngeal dysphagia: A comparison study of videofluoroscopic and sonar doppler
por: Abdulmassih, Edna Márcia da Silva, et al.
Publicado: (2013)

Retinal amyloid angiopathy
por: Meira, Alex Tiburtino, et al.
Publicado: (2021)

Post-Stroke Spastic Movement Disorder and Botulinum Toxin A Therapy: Early Detection And Early Injection
por: Wissel, Jörg, et al.
Publicado: (2023)

Cognitive dysfunction and dementia in movement disorders
por: Barbosa, Egberto Reis, et al.
Publicado: (2016)

Rita Levi-Montalcini: the neurologist who challenged fascism
por: Coutinho, Léo, et al.
Publicado: (2023)

Diffusion of Botulinum Toxins
por: Brodsky, Matthew A., et al.
Publicado: (2012)

Wernicke's encephalopathy with chorea: Neuroimaging findings
por: Sabatini, Jivago S., et al.
Publicado: (2016)

Botulinum toxin therapy: functional silencing of salivary disorders
por: Lovato, A., et al.
Publicado: (2017)

Case report: Successful autologous hematopoietic stem cell transplantation in a patient with GAD antibody-spectrum disorder with rapidly progressive dementia
por: Disserol, Caio César Diniz, et al.
Publicado: (2023)

Use of botulinum toxin in musculoskeletal pain
por: Singh, Jasvinder A
Publicado: (2013)

Patient Knowledge, Attitude and Perceptions towards Botulinum Toxin Treatment for Movement Disorders in India
por: Mol, Thavasimuthu Nisha, et al.
Publicado: (2021)

Impact of Disrupted Botulinum Toxin Therapy in Movement Disorders Due to COVID-19 Pandemic
por: Neeraja, Koti, et al.
Publicado: (2021)

Therapeutic Use of Botulinum Toxin in Neurorehabilitation
por: Intiso, Domenico
Publicado: (2012)

Use of botulinum toxin for voiding dysfunction
por: Eldred-Evans, David, et al.
Publicado: (2017)

Botulinum Toxin in Neurogenic Detrusor Overactivity
por: D'Ancona, Carlos Arturo Levi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_s41fqie0uc3qgt6mnl66mjpjro